Daniel Loeb’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-108,250
Closed -$93.9M 56
2022
Q3
$93.9M Hold
108,250
1.7% 17
2022
Q2
$47.4M Sell
108,250
-6,750
-6% -$3.52M 1.12% 19
2022
Q1
$73M Buy
115,000
+2,158
+2% +$1.36M 0.95% 28
2021
Q4
$101M Buy
112,842
+2,000
+2% +$2.1M 0.7% 33
2021
Q3
$141M Hold
110,842
0.77% 32
2021
Q2
$134M Buy
110,842
+90,000
+432% +$121M 0.79% 35
2021
Q1
$27.6M Sell
20,842
-36,658
-64% -$51.9M 0.19% 56
2020
Q4
$77.1M Buy
+57,500
New +$65.8M 0.59% 39

Other funds holding CANO

Daniel Loeb's CANO Position: Q4 2022 in Review

Daniel Loeb sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 108,250 shares — an estimated $93.9M sold.

Daniel Loeb first reported a position in CANO in Q4 2020 and held it in 8 quarters. The position peaked at $141M in Q3 2021. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

  • Daniel Loeb reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Daniel Loeb sold 108,250 Cano Health, Inc. shares in Q4 2022, an estimated $93.9M.
  • Daniel Loeb first reported a position in Cano Health, Inc. in Q4 2020 and held it in 8 quarters.
  • Daniel Loeb's Cano Health, Inc. position peaked at $141M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Third Point's 13F filing for Q4 2022, filed 14 Feb 2023.